-
Cost-Effectiveness of Proton Beam Therapy in the Treatment of Pediatric Medulloblastoma in France
Sep 9, 2025, 16:22 PM -
Potential Implications of EU Joint Clinical Assessment (JCA) for the UK Affiliate of a Global Pharmaceutical Company
Sep 9, 2025, 16:22 PM -
Comparative Effectiveness of Second-Line Antidiabetic Medications on the Risk of Major Adverse Cardiovascular Events: A Real-World Study in China
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Composite Materials for Hard Dental Tissue Defect Restorations From Budget Financing in Wartime in Ukraine
Sep 9, 2025, 16:22 PM -
Identifying Risk Profiles for Early Treatment Discontinuation in Geographic Atrophy Using Machine Learning and SHAP Clustering
Sep 9, 2025, 16:22 PM -
Systematic Review of Effectiveness of SGLT2 Inhibitors in Patients With Type 2 Diabetes With Focus on Glucose Levels, Cardiovascular Events, and Renal Function
Sep 9, 2025, 16:22 PM -
How Can Intravitreal Aflibercept 8 mg Impact Treatment Burden and Costs in European Patients With Diabetic Macular Edema? From Clinical Trials to Clinical Practice
Sep 9, 2025, 16:22 PM -
Health Utilities Among Patients With Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Economic Evaluation Frameworks for AI-Based Digital Health Technologies Across Four HTA Systems
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Familial Hypercholesterolemia Cascade Testing in Thailand: A Comparative Analysis of Exome vs. Long-Read DNA Sequencing
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Direct Oral Anticoagulants vs. Vitamin K Antagonists in Algeria: A Public Payer Perspective
Sep 9, 2025, 16:22 PM -
Exploring Knowledge Attitudes and Perspectives on Respiratory Viruses Vaccination Among Older Adults in the US
Sep 9, 2025, 16:22 PM -
Decoding Asthma: A Tale of Two Databases
Sep 9, 2025, 16:22 PM -
Economic Burden of Pneumococcal Disease—Impact of Age and Underlying Medical Conditions
Sep 9, 2025, 16:22 PM -
Implementation and Outcomes of Managed Entry Agreements Across the Nordic Region
Sep 9, 2025, 16:22 PM -
Comparative Efficacy and Safety of Avacincaptad Pegol vs. Pegcetacoplan in Treatment of Geographic Atrophy: Insights From a Multilevel Network Meta-Regression
Sep 9, 2025, 16:22 PM -
The Landscape of the Use of Artificial Intelligence and Machine Learning (AIMI) Methods in Health Technology Assessment (HTA) Submissions
Sep 9, 2025, 16:22 PM -
Analysis of HTA Decisions in Five European Countries for High Medical Need Products Approved by EMA
Sep 9, 2025, 16:22 PM -
Evaluating Patient Preferences for Clinical Trial Endpoints in Early Stage Cancer: A Discrete Choice Experiment in Canada
Sep 9, 2025, 16:22 PM -
Economic Evaluations Cost and Resource Utilization in Early Triple-Negative and Low Hormone Receptor-Positive Breast Cancer: A Comprehensive Systematic Review
Sep 9, 2025, 16:22 PM
